Anti-atherogenic activity of the calcium channel blocker isradipine (PN-200-110): a novel effect on matrix synthesis independent of calcium channel blockade.

Heider, J G; Weinstein, D B; Pickens, C E; Lan, S; Su, C M

Heider, J G; Weinstein, D B; Pickens, C E; Lan, S; Su, C M.

Transplant Proc ; 19(4 Suppl 5): 96-101, 1987 Aug.

Article in En | MEDLINE | ID: mdl-2956747

Subject(s)

Arteries/metabolism; Arteriosclerosis/prevention & control; Calcium Channel Blockers/pharmacology; Protein Biosynthesis; Pyridines/pharmacology; Animals; Arteries/drug effects; Arteries/pathology; Arteriosclerosis/pathology; Cells, Cultured; Cholesterol, Dietary/administration & dosage; Diet, Atherogenic; Humans; Hyperplasia; Isradipine; Rabbits; Rats

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arteries / Arteriosclerosis / Pyridines / Protein Biosynthesis / Calcium Channel Blockers Limits: Animals / Humans Language: En Journal: Transplant Proc Year: 1987 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links